Hokko Chemical Industry (4992) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Oct, 2026Executive summary
9M revenue rose 2.9% YoY to ¥39,261m, led by agricultural chemicals growth; operating income fell 7.7% to ¥4,468m amid higher costs and fine chemicals price competition.
Ordinary income declined ¥329m to ¥5,250m, while net income attributable to owners rose 2.3% to ¥3,708m on securities-sale gains and lower tax expense.
Financial highlights
Gross profit was ¥10,024m; EPS rose to ¥136.91 from ¥133.82 a year earlier.
Comprehensive income fell 25.0% YoY to ¥3,435m, mainly due to negative securities valuation and currency translation adjustments.
Outlook and guidance
FY2024 forecast remains unchanged: revenue ¥46,000m, operating income ¥4,120m, ordinary income ¥5,100m and net income attributable to owners ¥3,450m.
9M progress against FY forecasts: revenue 85.4%, operating income 108.4%, ordinary income 102.9% and net income 107.5%.
Forecast results remain subject to macroeconomic, market, industry and other internal or external factors.
Latest events from Hokko Chemical Industry
- Pesticide growth lifted revenue, but fine-chemical weakness cut Q1 profits.4992
Q1 2024 - H1 revenue and net income rose, while operating income fell amid cost pressure.4992
Q2 2024 - FY2024 earnings grew; FY2025 guidance projects higher sales and operating profit.4992
Q4 2024 - Pesticide-led growth lifted Q1 revenue; Fine Chemicals profit fell, and 5% of shares were canceled.4992
Q1 2025 - Pesticide-led growth lifted profit; earnings guidance held as the dividend forecast rose.4992
Q3 2025 - Agrochemical-led Q1 growth accompanied higher FY2029 targets.4992
Q1 2026 - Pesticide-led growth lifted H1 results as fine chemicals weakened; a buyback was approved.4992
Q2 2025 - Record ordinary profit and strong agrochemical sales; FY2026 dividend projected higher.4992
Q4 2025 - Agriculture-led H1 growth; guidance maintained and a ¥2bn share buyback approved.4992
Q2 2026